BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 14636671)

  • 1. Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function.
    Spector AA; Fang X; Snyder GD; Weintraub NL
    Prog Lipid Res; 2004 Jan; 43(1):55-90. PubMed ID: 14636671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Action of epoxyeicosatrienoic acids on cellular function.
    Spector AA; Norris AW
    Am J Physiol Cell Physiol; 2007 Mar; 292(3):C996-1012. PubMed ID: 16987999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The factor in EDHF: Cytochrome P450 derived lipid mediators and vascular signaling.
    Fleming I
    Vascul Pharmacol; 2016 Nov; 86():31-40. PubMed ID: 26975734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arachidonic acid cytochrome P450 epoxygenase pathway.
    Spector AA
    J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S52-6. PubMed ID: 18952572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond vasodilatation: non-vasomotor roles of epoxyeicosatrienoic acids in the cardiovascular system.
    Larsen BT; Campbell WB; Gutterman DD
    Trends Pharmacol Sci; 2007 Jan; 28(1):32-8. PubMed ID: 17150260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increases in levels of epoxyeicosatrienoic and dihydroxyeicosatrienoic acids (EETs and DHETs) in liver and heart in vivo by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and in hepatic EET:DHET ratios by cotreatment with TCDD and the soluble epoxide hydrolase inhibitor AUDA.
    Diani-Moore S; Ma Y; Gross SS; Rifkind AB
    Drug Metab Dispos; 2014 Feb; 42(2):294-300. PubMed ID: 24311719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epoxyeicosatrienoic acids, 20-hydroxyeicosatetraenoic acid, and renal microvascular function.
    Imig JD
    Prostaglandins Other Lipid Mediat; 2013; 104-105():2-7. PubMed ID: 23333581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased epoxyeicosatrienoic acids and reduced soluble epoxide hydrolase expression in the preeclamptic placenta.
    Dalle Vedove F; Fava C; Jiang H; Zanconato G; Quilley J; Brunelli M; Guglielmi V; Vattemi G; Minuz P
    J Hypertens; 2016 Jul; 34(7):1364-70. PubMed ID: 27115337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crosstalk between adenosine receptors and CYP450-derived oxylipins in the modulation of cardiovascular, including coronary reactive hyperemic response.
    Nayeem MA; Hanif A; Geldenhuys WJ; Agba S
    Pharmacol Ther; 2022 Dec; 240():108213. PubMed ID: 35597366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epoxide hydrolases regulate epoxyeicosatrienoic acid incorporation into coronary endothelial phospholipids.
    Weintraub NL; Fang X; Kaduce TL; VanRollins M; Chatterjee P; Spector AA
    Am J Physiol; 1999 Nov; 277(5):H2098-108. PubMed ID: 10564166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute mercury toxicity modulates cytochrome P450, soluble epoxide hydrolase and their associated arachidonic acid metabolites in C57Bl/6 mouse heart.
    Amara IE; Elshenawy OH; Abdelrady M; El-Kadi AO
    Toxicol Lett; 2014 Apr; 226(1):53-62. PubMed ID: 24472606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble epoxide hydrolase inhibition reveals novel biological functions of epoxyeicosatrienoic acids (EETs).
    Inceoglu B; Schmelzer KR; Morisseau C; Jinks SL; Hammock BD
    Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):42-9. PubMed ID: 17164131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathways of epoxyeicosatrienoic acid metabolism in endothelial cells. Implications for the vascular effects of soluble epoxide hydrolase inhibition.
    Fang X; Kaduce TL; Weintraub NL; Harmon S; Teesch LM; Morisseau C; Thompson DA; Hammock BD; Spector AA
    J Biol Chem; 2001 May; 276(18):14867-74. PubMed ID: 11278979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome p450 and vascular homeostasis.
    Fleming I
    Circ Res; 2001 Oct; 89(9):753-62. PubMed ID: 11679404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular pharmacology of epoxyeicosatrienoic acids.
    Pfister SL; Gauthier KM; Campbell WB
    Adv Pharmacol; 2010; 60():27-59. PubMed ID: 21081214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of forskolin-induced cAMP production by cytochrome P450 epoxygenase metabolites of arachidonic acid in HEK293 cells.
    Abukhashim M; Wiebe GJ; Seubert JM
    Cell Biol Toxicol; 2011 Oct; 27(5):321-32. PubMed ID: 21519968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epoxide hydrolase activities and epoxy fatty acids in the mosquito Culex quinquefasciatus.
    Xu J; Morisseau C; Yang J; Mamatha DM; Hammock BD
    Insect Biochem Mol Biol; 2015 Apr; 59():41-9. PubMed ID: 25686802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of cytochrome P450-epoxygenase and soluble epoxide hydrolase in the regulation of vascular response.
    Nayeem MA; Geldenhuys WJ; Hanif A
    Adv Pharmacol; 2023; 97():37-131. PubMed ID: 37236764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epoxyeicosatrienoic acids and endothelium-dependent responses.
    Campbell WB; Fleming I
    Pflugers Arch; 2010 May; 459(6):881-95. PubMed ID: 20224870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological inhibition of the soluble epoxide hydrolase-from mouse to man.
    Revermann M
    Curr Opin Pharmacol; 2010 Apr; 10(2):173-8. PubMed ID: 20079692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.